Late-onset angioedema due to an angiotensin-converting enzyme inhibitor

被引：5
作者：
Garcia-Pavia, Pablo
Tomas, Jose M.
Alonso-Pulpon, Luis
机构：
[1] Puerta de Hierro Univ Hosp, Dept Cardiol, Madrid 28035, Spain
[2] Puerta de Hierro Univ Hosp, Dept Ophthalmol, Madrid 28035, Spain
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2007年 / 23卷 / 04期
关键词：
angioedema; angiotensin-converting enzyme inhibitor; hypertension; late onset;
D O I：
10.1016/S0828-282X(07)70762-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Angioedema is a rare but potentially life-threatening adverse effect of angiotensin-converting enzyme inhibitors. A patient who presented with facial angioedema four months after initiating antihypertensive treatment with enalapril is described. Angioedema due to angiotensin-converting enzyme inhibitors usually appears during the first weeks of treatment. Late-onset angioedema is often unrecognized.
引用
收藏
页码：315 / 316
页数：2
相关论文
共 4 条
  • [1] ANGIO-EDEMA IN RELATION TO TREATMENT WITH ANGIOTENSIN CONVERTING ENZYME-INHIBITORS
    HEDNER, T
    SAMUELSSON, O
    LUNDE, H
    LINDHOLM, L
    ANDREN, L
    WIHOLM, BE
    [J]. BRITISH MEDICAL JOURNAL, 1992, 304 (6832) : 941 - 946
  • [2] Incidence and characteristics of angioedema associated with enalapril
    Kostis, JB
    Kim, HJ
    Rusnak, J
    Casale, T
    Kaplan, A
    Corren, J
    Levy, E
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (14) : 1637 - 1642
  • [3] Sabroe RA, 1997, BRIT J DERMATOL, V136, P153
  • [4] Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema - Clinical experience at a large community teaching hospital
    Sondhi, D
    Lippmann, M
    Murali, G
    [J]. CHEST, 2004, 126 (02) : 400 - 404
1